Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health...
from NDTV News - Topstories https://ift.tt/3lXILh9
from NDTV News - Topstories https://ift.tt/3lXILh9
Comments
Post a Comment